{"id":1456,"date":"2024-10-16T10:11:46","date_gmt":"2024-10-16T04:41:46","guid":{"rendered":"https:\/\/ainews.prativad.com\/index.php\/experimental-als-drug-could-offer-new-hope-for-patients-if-approved-researchers-say\/"},"modified":"2024-10-16T10:11:46","modified_gmt":"2024-10-16T04:41:46","slug":"experimental-als-drug-could-offer-new-hope-for-patients-if-approved-researchers-say","status":"publish","type":"post","link":"https:\/\/ainews.prativad.com\/index.php\/experimental-als-drug-could-offer-new-hope-for-patients-if-approved-researchers-say\/","title":{"rendered":"Experimental ALS drug could offer new hope for patients if approved, researchers say"},"content":{"rendered":"<div style=\"margin-top: 0px; margin-bottom: 0px;\" class=\"sharethis-inline-share-buttons\" ><\/div><p>New hope could be on the horizon for <a href=\"https:\/\/www.foxnews.com\/category\/health\/nervous-system-health\/als\" target=\"_blank\" rel=\"noopener\">ALS patients<\/a> in the form of a &#8220;breakthrough&#8221; drug, researchers say.<\/p>\n<p>Neuvivo, a California biopharmaceutical company that develops therapies for neurodegenerative diseases, is seeking approval for a <a href=\"https:\/\/www.foxnews.com\/category\/health\/healthy-living\/medications\" target=\"_blank\" rel=\"noopener\">new medication<\/a> for ALS (amyotrophic lateral sclerosis).<\/p>\n<p>ALS is a progressive neurodegenerative disease that gradually impairs muscle function, eventually robbing the patient of the ability to walk, talk, eat and even breathe, per the ALS Association.<\/p>\n<p><a href=\"https:\/\/www.foxnews.com\/lifestyle\/mom-als-florida-mother-son-wedding-dance\" target=\"_blank\" rel=\"noopener\"><strong>MOM WITH ALS SHARES MOTHER-SON WEDDING DANCE IN FLORIDA<\/strong><\/a><\/p>\n<p>This month, Neuvivo submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for NP001 (sodium chlorite infusion).<\/p>\n<p>The drug has been granted orphan drug and fast track designations by the FDA and is eligible for Accelerated Approval and Priority Review, which could shorten the time to a potential approval, according to a press release.<\/p>\n<p>&#8220;If approved, NP001 would be the first immunotherapy for ALS, and the first ALS treatment shown to preserve lung function,&#8221; Matthew W. Davis, MD, chief medical officer of Neuvivo, told Fox News Digital.<\/p>\n<p>There are currently no FDA-approved treatments for ALS that <a href=\"https:\/\/www.foxnews.com\/category\/health\/respiratory-health\" target=\"_blank\" rel=\"noopener\">preserve breathing function<\/a> or extend life by more than two or three months, the company noted.<\/p>\n<p>The leading cause of death in patients with ALS is loss of lung function (respiratory failure).<\/p>\n<p><a href=\"https:\/\/www.foxnews.com\/health\/man-paralyzed-diving-mishap-medical-miracle-year-after-ai-powered-brain-implant\" target=\"_blank\" rel=\"noopener\"><strong>MAN PARALYZED IN DIVING MISHAP HAS MEDICAL MIRACLE A YEAR AFTER AI-POWERED BRAIN IMPLANT<\/strong><\/a><\/p>\n<p>Approximately 30,000 adults in the U.S. are currently living with ALS, and one in 300 people will be diagnosed in their lifetime.<\/p>\n<p>The average life expectancy after a patient is diagnosed with ALS is 18 months.<\/p>\n<p>&#8220;Half of the people living with ALS today will unfortunately not likely be living in three years,&#8221; Davis said.<\/p>\n<p>Dr. Earnest Lee Murray, a\u00a0<a href=\"https:\/\/www.foxnews.com\/category\/health\/healthy-living\/health-care\" target=\"_blank\" rel=\"noopener\">board-certified neurologist<\/a> at Jackson-Madison County General Hospital in Jackson, Tennessee, confirmed that current ALS treatments are &#8220;very limited&#8221; in their effectiveness.\u00a0<\/p>\n<p>While existing drugs combat ALS through the nervous system, NP001 \u2014 if approved \u2014 would be the first therapy that works by controlling inflammation in the immune system.<\/p>\n<p>&#8220;NP001 would be indicated for all patients with ALS, although our data supports that patients with inflammation are likely to have significantly greater benefit,&#8221; Davis said.<\/p>\n<p>Murray, who is not affiliated with Neuvivo, noted that excessive inflammation has been a known factor in the progression of <a href=\"https:\/\/www.foxnews.com\/category\/health\/nutrition-and-fitness\/fitness\" target=\"_blank\" rel=\"noopener\">muscle weakness<\/a> in ALS.\u00a0<\/p>\n<p>While initial studies of NP001 did not show any &#8220;statistically significant&#8221; improvement, the neurologist said, &#8220;reanalysis of the previous data looked at certain subgroups of patients with particularly high inflammatory markers.&#8221;<\/p>\n<p>&#8220;This data suggests that NP001 can slow progressive loss of muscle function, especially when it comes to a patient\u2019s ability to breathe, by targeting a specific immune system cell called a macrophage,&#8221; Murray told Fox News Digital.<\/p>\n<p>&#8220;Halting the activation of macrophages oftentimes can have an effect on other immune cells, which will hopefully alter the progression of ALS.&#8221;<\/p>\n<p>During the first month of treatment, NP001 is given as a 30-minute infusion each day for five consecutive days, according to Davis.<\/p>\n<p>Every month thereafter, the medication is given for three consecutive days in the same way.<\/p>\n<p><a href=\"https:\/\/www.foxnews.com\/newsletters?cmpid=fnfirstnl\" target=\"_blank\" rel=\"noopener\"><strong>CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER<\/strong><\/a><\/p>\n<p>NP001 was &#8220;<a href=\"https:\/\/www.foxnews.com\/health\" target=\"_blank\" rel=\"noopener\">generally well-tolerated<\/a>&#8221; in clinical trials, Davis said.<\/p>\n<p>The most commonly reported side effect was pain, redness and swelling where the drug was infused, which were &#8220;generally transitory and mild.&#8221;<\/p>\n<p>Murray echoed that early studies have demonstrated that NP001 is safe and well-tolerated.\u00a0<\/p>\n<p>&#8220;I am cautiously optimistic that as NP001 moves though the FDA process of <a href=\"https:\/\/www.foxnews.com\/category\/health\/medical-research\" target=\"_blank\" rel=\"noopener\">clinical trials<\/a>, it will show true improvement in ALS patients and offer some hope to patients and families dealing with this devastating disease,&#8221; he said.<\/p>\n<p><a href=\"https:\/\/www.foxnews.com\/health\" target=\"_blank\" rel=\"noopener\"><strong>For more Health articles, visit\u00a0<\/strong><\/a><a href=\"http:\/\/www.foxnews.com\/health\" target=\"_blank\" rel=\"noopener\"><strong>www.foxnews.com\/health<\/strong><\/a><\/p>\n<p>As the drug undergoes FDA review, Neuvivo will continue to post updates for patients and caregivers on its website, according to Davis.<\/p>","protected":false},"excerpt":{"rendered":"<p>New hope could be on the horizon for ALS patients in the form of a &#8220;breakthrough&#8221; drug, researchers say. Neuvivo, a California biopharmaceutical company that develops&hellip;<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"footnotes":""},"categories":[8,5],"tags":[],"class_list":["post-1456","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health-news","category-top-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Experimental ALS drug could offer new hope for patients if approved, researchers say - Leading the AI News Frontier<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ainews.prativad.com\/index.php\/experimental-als-drug-could-offer-new-hope-for-patients-if-approved-researchers-say\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Experimental ALS drug could offer new hope for patients if approved, researchers say - Leading the AI News Frontier\" \/>\n<meta property=\"og:description\" content=\"New hope could be on the horizon for ALS patients in the form of a &#8220;breakthrough&#8221; drug, researchers say. Neuvivo, a California biopharmaceutical company that develops&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ainews.prativad.com\/index.php\/experimental-als-drug-could-offer-new-hope-for-patients-if-approved-researchers-say\/\" \/>\n<meta property=\"og:site_name\" content=\"Leading the AI News Frontier\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-16T04:41:46+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ainews.prativad.com\/index.php\/experimental-als-drug-could-offer-new-hope-for-patients-if-approved-researchers-say\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ainews.prativad.com\/index.php\/experimental-als-drug-could-offer-new-hope-for-patients-if-approved-researchers-say\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Experimental ALS drug could offer new hope for patients if approved, researchers say\",\"datePublished\":\"2024-10-16T04:41:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ainews.prativad.com\/index.php\/experimental-als-drug-could-offer-new-hope-for-patients-if-approved-researchers-say\/\"},\"wordCount\":646,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/ainews.prativad.com\/#organization\"},\"articleSection\":[\"Health News\",\"Top News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ainews.prativad.com\/index.php\/experimental-als-drug-could-offer-new-hope-for-patients-if-approved-researchers-say\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ainews.prativad.com\/index.php\/experimental-als-drug-could-offer-new-hope-for-patients-if-approved-researchers-say\/\",\"url\":\"https:\/\/ainews.prativad.com\/index.php\/experimental-als-drug-could-offer-new-hope-for-patients-if-approved-researchers-say\/\",\"name\":\"Experimental ALS drug could offer new hope for patients if approved, researchers say - Leading the AI News Frontier\",\"isPartOf\":{\"@id\":\"https:\/\/ainews.prativad.com\/#website\"},\"datePublished\":\"2024-10-16T04:41:46+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/ainews.prativad.com\/index.php\/experimental-als-drug-could-offer-new-hope-for-patients-if-approved-researchers-say\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ainews.prativad.com\/index.php\/experimental-als-drug-could-offer-new-hope-for-patients-if-approved-researchers-say\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ainews.prativad.com\/index.php\/experimental-als-drug-could-offer-new-hope-for-patients-if-approved-researchers-say\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ainews.prativad.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Experimental ALS drug could offer new hope for patients if approved, researchers say\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ainews.prativad.com\/#website\",\"url\":\"https:\/\/ainews.prativad.com\/\",\"name\":\"Leading the AI News Frontier\",\"description\":\"Empowering You with AI Intelligence\",\"publisher\":{\"@id\":\"https:\/\/ainews.prativad.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ainews.prativad.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ainews.prativad.com\/#organization\",\"name\":\"Leading the AI News Frontier\",\"url\":\"https:\/\/ainews.prativad.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ainews.prativad.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ainews.prativad.com\/wp-content\/uploads\/2024\/09\/AInews.png\",\"contentUrl\":\"https:\/\/ainews.prativad.com\/wp-content\/uploads\/2024\/09\/AInews.png\",\"width\":300,\"height\":72,\"caption\":\"Leading the AI News Frontier\"},\"image\":{\"@id\":\"https:\/\/ainews.prativad.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Experimental ALS drug could offer new hope for patients if approved, researchers say - Leading the AI News Frontier","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ainews.prativad.com\/index.php\/experimental-als-drug-could-offer-new-hope-for-patients-if-approved-researchers-say\/","og_locale":"en_US","og_type":"article","og_title":"Experimental ALS drug could offer new hope for patients if approved, researchers say - Leading the AI News Frontier","og_description":"New hope could be on the horizon for ALS patients in the form of a &#8220;breakthrough&#8221; drug, researchers say. Neuvivo, a California biopharmaceutical company that develops&hellip;","og_url":"https:\/\/ainews.prativad.com\/index.php\/experimental-als-drug-could-offer-new-hope-for-patients-if-approved-researchers-say\/","og_site_name":"Leading the AI News Frontier","article_published_time":"2024-10-16T04:41:46+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ainews.prativad.com\/index.php\/experimental-als-drug-could-offer-new-hope-for-patients-if-approved-researchers-say\/#article","isPartOf":{"@id":"https:\/\/ainews.prativad.com\/index.php\/experimental-als-drug-could-offer-new-hope-for-patients-if-approved-researchers-say\/"},"author":{"name":"","@id":""},"headline":"Experimental ALS drug could offer new hope for patients if approved, researchers say","datePublished":"2024-10-16T04:41:46+00:00","mainEntityOfPage":{"@id":"https:\/\/ainews.prativad.com\/index.php\/experimental-als-drug-could-offer-new-hope-for-patients-if-approved-researchers-say\/"},"wordCount":646,"commentCount":0,"publisher":{"@id":"https:\/\/ainews.prativad.com\/#organization"},"articleSection":["Health News","Top News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ainews.prativad.com\/index.php\/experimental-als-drug-could-offer-new-hope-for-patients-if-approved-researchers-say\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ainews.prativad.com\/index.php\/experimental-als-drug-could-offer-new-hope-for-patients-if-approved-researchers-say\/","url":"https:\/\/ainews.prativad.com\/index.php\/experimental-als-drug-could-offer-new-hope-for-patients-if-approved-researchers-say\/","name":"Experimental ALS drug could offer new hope for patients if approved, researchers say - Leading the AI News Frontier","isPartOf":{"@id":"https:\/\/ainews.prativad.com\/#website"},"datePublished":"2024-10-16T04:41:46+00:00","breadcrumb":{"@id":"https:\/\/ainews.prativad.com\/index.php\/experimental-als-drug-could-offer-new-hope-for-patients-if-approved-researchers-say\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ainews.prativad.com\/index.php\/experimental-als-drug-could-offer-new-hope-for-patients-if-approved-researchers-say\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ainews.prativad.com\/index.php\/experimental-als-drug-could-offer-new-hope-for-patients-if-approved-researchers-say\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ainews.prativad.com\/"},{"@type":"ListItem","position":2,"name":"Experimental ALS drug could offer new hope for patients if approved, researchers say"}]},{"@type":"WebSite","@id":"https:\/\/ainews.prativad.com\/#website","url":"https:\/\/ainews.prativad.com\/","name":"Leading the AI News Frontier","description":"Empowering You with AI Intelligence","publisher":{"@id":"https:\/\/ainews.prativad.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ainews.prativad.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ainews.prativad.com\/#organization","name":"Leading the AI News Frontier","url":"https:\/\/ainews.prativad.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ainews.prativad.com\/#\/schema\/logo\/image\/","url":"https:\/\/ainews.prativad.com\/wp-content\/uploads\/2024\/09\/AInews.png","contentUrl":"https:\/\/ainews.prativad.com\/wp-content\/uploads\/2024\/09\/AInews.png","width":300,"height":72,"caption":"Leading the AI News Frontier"},"image":{"@id":"https:\/\/ainews.prativad.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/ainews.prativad.com\/index.php\/wp-json\/wp\/v2\/posts\/1456","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ainews.prativad.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ainews.prativad.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/ainews.prativad.com\/index.php\/wp-json\/wp\/v2\/comments?post=1456"}],"version-history":[{"count":0,"href":"https:\/\/ainews.prativad.com\/index.php\/wp-json\/wp\/v2\/posts\/1456\/revisions"}],"wp:attachment":[{"href":"https:\/\/ainews.prativad.com\/index.php\/wp-json\/wp\/v2\/media?parent=1456"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ainews.prativad.com\/index.php\/wp-json\/wp\/v2\/categories?post=1456"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ainews.prativad.com\/index.php\/wp-json\/wp\/v2\/tags?post=1456"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}